You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
Looking for something fast? We’ve bundled together our best content on today’s important nutritional science topics so you can find what you need right away.
Filters
Showing: {{1}}-{{9}} results of {{count}}
We're sorry! We weren't able to find the match. Please double check your search for any spelling errors. You can also try a different search term
COPD patients often experience reduced respiratory muscle endurance, which can impact disease trajectory. Early assessment and intervention is critical to improve patient outcomes.

COPD patients often experience reduced respiratory muscle endurance, which can impact disease trajectory. Early assessment and intervention is critical to improve patient outcomes.
Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs).
![]()
Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs). Rupert was admitted to hospital with gastroenteritis and poorly controlled angina. He develop loose stools (type 7 on the Bristol Stool Chart) which persisted for four weeks and Metronidazole was prescribed for suspected C.difficile. His loose watery stools persisted and after a flexible sigmoidoscopy and colonoscopy were performed, Rupert was diagnosed with non-infective gastroenteritis and colitis. Codeine phosphate, Citalopram, Omeprazole, Prednisolone were trialled during this time. Rupert was only managing to consume a quarter of his meals and was prescribed whole protein oral nutritional supplements (ONS).

Care pathways are typically in the form of a flow chart to provide guidance and best practice.
Readmission and Mortality in Malnourished, Older, Hospitalized Adults


The NOURISH (Nutritional effect on unplanned readmissions and survival in hospitalised patients) study evaluates the impact of a high protein oral nutritional supplement containing β-hydroxy-β-methylbutyrate (HMB) on mortality and hospital readmission rates in malnourished hospitalised older adults with a range of cardiopulmonary conditions up to 90 days post-discharge.
UK-N/A-2200454 (V2) | November 2025
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.